Citius Oncology Inc (CTOR)
1.20
+0.17
(+16.98%)
USD |
NASDAQ |
Nov 05, 16:00
1.18
-0.02
(-1.67%)
After-Hours: 19:03
Citius Oncology Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 4.240M |
| Date | Value |
|---|---|
| September 30, 2022 | 3.428M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.428M
Minimum
2022
4.240M
Maximum
2023
3.834M
Average
3.834M
Median
Research and Development Expense (Annual) Benchmarks
| Citius Pharmaceuticals Inc | 14.82M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.31M |